| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0009940> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0021055> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0039194> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C0275522> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C5392990> <https://research.tib.eu/covid-19/entity/32979941_HAS_TOPIC_C5392991>
?:authorAffiliation	[\'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Clinical Interventions and Technology, Karolinska Institutet, Stockholm, Sweden; Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.\', \'Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.\', \'Childhood Cancer Research Unit, Department of Women\'s and Children\'s Health, Karolinska Institutet, Stockholm, Sweden; Theme of Children\'s and Women\'s Health, Karolinska University Hospital, Stockholm, Sweden.\', \'Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Health Technology, Technical University of Denmark, Lyngby, Denmark; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Argentina.\', \'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK; Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: marcus.buggert@ki.se.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Albert_Jan> <https://research.tib.eu/covid-19/entity/Aleman_Soo> <https://research.tib.eu/covid-19/entity/Allander_Tobias> <https://research.tib.eu/covid-19/entity/Bj%C3%B6rkstr%C3%B6m_Niklas_K> <https://research.tib.eu/covid-19/entity/Bogdanovic_Gordana> <https://research.tib.eu/covid-19/entity/Buggert_Marcus> <https://research.tib.eu/covid-19/entity/Emg%C3%A5rd_Johanna> <https://research.tib.eu/covid-19/entity/Eriksson_Lars_I> <https://research.tib.eu/covid-19/entity/Folkesson_Elin> <https://research.tib.eu/covid-19/entity/Gorin_Jean-Baptiste> <https://research.tib.eu/covid-19/entity/Gredmark-Russ_Sara> <https://research.tib.eu/covid-19/entity/Henter_Jan-Inge> <https://research.tib.eu/covid-19/entity/Kamal_Habiba> <https://research.tib.eu/covid-19/entity/Kammann_Tobias> <https://research.tib.eu/covid-19/entity/Klingstr%C3%B6m_Jonas> <https://research.tib.eu/covid-19/entity/Ljunggren_Hans-Gustaf> <https://research.tib.eu/covid-19/entity/Llewellyn-Lacey_Sian> <https://research.tib.eu/covid-19/entity/Muschiol_Sandra> <https://research.tib.eu/covid-19/entity/Nielsen_Morten> <https://research.tib.eu/covid-19/entity/Olsson_Annika> <https://research.tib.eu/covid-19/entity/Parrot_Tiphaine> <https://research.tib.eu/covid-19/entity/Perez-Potti_Andr%C3%A9> <https://research.tib.eu/covid-19/entity/Price_David_A> <https://research.tib.eu/covid-19/entity/Rivera-Ballesteros_Olga> <https://research.tib.eu/covid-19/entity/Rooyackers_Olav> <https://research.tib.eu/covid-19/entity/S%C3%B6nnerborg_Anders> <https://research.tib.eu/covid-19/entity/Sandberg_Johan_K> <https://research.tib.eu/covid-19/entity/Sekine_Takuya> <https://research.tib.eu/covid-19/entity/Str%C3%A5lin_Kristoffer> <https://research.tib.eu/covid-19/entity/Wullimann_David_J>
?:doi	<https://research.tib.eu/covid-19/entity/S0092-8674%2820%2931008-410.1016/j.cell.2020.08.017>
?:doi	S0092-8674(20)31008-410.1016/j.cell.2020.08.017
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Cell
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32979941>
?:pmid	<https://research.tib.eu/covid-19/entity/32979941>
?:pmid	32979941
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	25.137
?:rankingScore_hIndex	682
?:title	Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Clinical Interventions and Technology, Karolinska Institutet, Stockholm, Sweden; Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.\', \'Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.\', \'Childhood Cancer Research Unit, Department of Women\'s and Children\'s Health, Karolinska Institutet, Stockholm, Sweden; Theme of Children\'s and Women\'s Health, Karolinska University Hospital, Stockholm, Sweden.\', \'Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Health Technology, Technical University of Denmark, Lyngby, Denmark; Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Argentina.\', \'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Division of Infectious Diseases, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK; Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: marcus.buggert@ki.se.\']

?:citedBy